NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Survodutide from Qing Li Peptide? Mail in a sample (US only) and let us test it.

Test my supply
+16 more ↓
48%
Finnrick rating
#4 of 7 Survodutide vendors
1 of 3 classifiable tests passed
natural 33%
methodology · Purity focus
Finnrick analysis · Survodutide

Qing Li Peptide's Survodutide record is mixed: two July identity/fill passes missed purity at 98.39–98.44%, then an October sample hit 99.86%. Trajectory improved, but sparse evidence and no batch ID on the clean result add uncertainty.

methodology →
vendor intelligence report
Vendor Intelligence Report: Qing Li Peptide

Qing Li now presents a closure notice while stale social channels and related storefronts keep the brand reachable. The report follows Hong Kong filings, shared sales-team photos, cloned Norco copy, and payment/refund trails without overstating unresolved ownership.

39 pages6 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.05
86%
38
2
Tirzepatide
$0.50
81%
46
3
Retatrutide
$0.97
80%
131
4
Ipamorelin
$0.60
71%
17
5
PT-141
-
69%
7
6
Semaglutide
$1.20
67%
3
7
Melanotan II
$0.40
66%
7
8
Cagrilintide
$1.80
54%
4
9
Sermorelin
$5.00
51%
6
10
Survodutideselected
$3.00
48%
3
11
BPC-157
$0.70
43%
36
12
Tesamorelin
$1.80
38%
25
13
CJC-1295
$1.40
35%
19
14
MOTS-c
$0.45
34%
6
15
TB-500
$1.20
26%
20
16
Epithalon
$0.50
-
0
17
GLOW
-
-
0
18
HGH
-
-
0
19
KLOW
$0.21
-
0
20
KPV
-
-
0
21
NAD+
$0.02
-
0
22
Pinealon
$0.45
-
0
23
SS-31
$0.44
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%14 Jul 2025: 25%14 Jul 2025: 23%3 Oct 2025: 42%15 Nov 2026: current 48%25%48%Jul 25Nov 26
Showing Survodutide tests only
Qing Li Peptide Survodutide test history
COA-backed lab tests

About Qing Li Peptide test results from Finnrick

Qing Li Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 15 peptides and 368 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Qing Li Peptide peptides in this dataset are BPC-157 (36 tests), Cagrilintide (4 tests) and CJC-1295 (19 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests. It also includes 1 correction related to this vendor.

Corrections
2026-03-04
Customer update
Sample potency on sample fz959qa was incorrectly captured as 0.10 mg, correct quantity was 10 mg.
Peptide testing

Ordered Survodutide from Qing Li Peptide? Mail in a sample (US only) and let us test it.

Test my supply